Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?
about
Zaleplon for insomniaZopiclone for insomniaZolpidem for insomniaDiscontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trialAn assessment of quality of sleep and the use of drugs with sedating properties in hospitalized adult patientsFactors associated with psychotropic drug use among community-dwelling older persons: A review of empirical studiesMexazolam: clinical efficacy and tolerability in the treatment of anxietyPregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activityGeneral practitioners' experiences and perceptions of benzodiazepine prescribing: systematic review and meta-synthesisWhat is Behind the Seeming Cessation of the Increase in Sleep Medicine Consumption in Finland During the Last Years?Treatment of insomnia in patients with mood disorders.Factors associated with long-term use of hypnotics among patients with chronic insomnia.Are GABAA receptors containing alpha5 subunits contributing to the sedative properties of benzodiazepine site agonists?Melancholic and reactive depression: a reappraisal of old categories.Medication dependence and anxiety.A randomized, controlled, double-blinded clinical trial of gabapentin 300 versus 900 mg versus placebo for anxiety symptoms in breast cancer survivors.Intimate partner violence and prescription of potentially addictive drugs: prospective cohort study of women in the Oslo Health StudyA benzodiazepine discontinuation programme does not increase the frequency of contacts with the family practice.Silexan in anxiety disorders: Clinical data and pharmacological background.Investigating the effect of hydro-alcoholic extract of Salix aegyptiaca on anxiety in male ratPsychological determinants of the intention to educate patients about benzodiazepines.The Efficacy and Safety of Clonazepam in Patients with Anxiety Disorder Taking Newer Antidepressants: A Multicenter Naturalistic StudyThe Impact of Benzodiazepine Use on Mortality Among Polysubstance Users in Vancouver, Canada.Ramelteon for insomnia symptoms in a community sample of adults with generalized anxiety disorder: an open label study.Anxiolytic effects of the GABA(A) receptor partial agonist, L-838,417: impact of age, test context familiarity, and stress.Effects of Chronic Vitamin D₃ Hormone Administration on Anxiety-Like Behavior in Adult Female Rats after Long-Term Ovariectomy.The intended and unintended consequences of benzodiazepine monitoring programmes: a review of the literature.Benzodiazepines revisited--will we ever learn?An orally administered lavandula oil preparation (Silexan) for anxiety disorder and related conditions: an evidence based review.Phytopharmaceutical treatment of anxiety, depression, and dementia in the elderly: evidence from randomized, controlled clinical trials.Drug misuse and diversion in adults prescribed anxiolytics and sedatives.The differential role of alpha1- and alpha5-containing GABA(A) receptors in mediating diazepam effects on spontaneous locomotor activity and water-maze learning and memory in rats.Treatment of out-patients with complicated benzodiazepine dependence: comparison of two approaches.[Evaluation of the medical orientation for the benzodiazepine side effects].[The PRISCUS list in clinical routine. Practicability and comparison to international PIM lists].Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disorder.Long-term effectiveness of computer-generated tailored patient education on benzodiazepines: a randomized controlled trial.Teaching young GPs to cope with psychosocial consultations without prescribing: a durable impact of an e-module on determinants of benzodiazepines prescribing.Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives.Glucagon-like peptide-1 (GLP-1) receptor agonist prevents development of tolerance to anti-anxiety effect of ethanol and withdrawal-induced anxiety in rats.
P2860
Q24200706-67CE2FC0-3C0B-4C3D-A04B-B1419EA178A2Q24200717-C5027EE0-7839-4095-8684-67FA3DA06872Q24200727-C2690262-8DE3-492E-BB9A-8231C5284584Q24650209-BD61D138-13C3-4437-86B4-16EB16B66019Q24797700-818212CF-4F77-4F34-AC07-BE3853FC3011Q24803987-4381C41C-0E58-4679-9A0E-A7FBEC8678D3Q28084954-B8363BD0-1E26-4A3A-AC5F-B7399637BC40Q28345790-37897C52-567A-4A4D-B1ED-B2BD420FBEA7Q33640837-37B3E6C6-483C-4452-BE54-2F8A103AFB6DQ34074150-CFB5A99D-2001-4B4B-8A6B-542CAA6B6882Q34378479-800AF8C7-2353-4ACA-8DF2-F021018BE05FQ34542810-CAE159AA-1AA9-4C23-A2D3-B40BEF3B51F0Q34613452-A0DCF70A-47D2-452E-8679-1130786688EBQ35044233-CC7B6DD3-73A5-424E-9299-0C085879852FQ35236337-658407B6-774B-4DEB-AAF1-A17D041A10EDQ35545279-1F8DEBC2-4220-469E-878F-71DF9BC811D9Q35882033-29CAFEB2-2C8A-49E3-A3EA-23B5825C6854Q36122041-0EA546C4-54C7-4F07-AB8F-0AAD9695D012Q36373457-C8BCAAD3-43EB-4902-B8BD-FFBB4AEC55DFQ36560937-B3AD3718-0A43-4FDE-8DAA-DA2FE2E57E49Q36785051-096D90B0-221A-40BB-8A8E-8F0966A05CDBQ36873006-7444C984-63AE-447C-BBDB-12DD30BEDF8CQ36906777-8DE28174-800C-4412-B3A5-894D053424DDQ37086857-3966CCE9-24D2-431D-BAAB-50EFBEFA90ADQ37151613-C82584EF-ECB8-4C9A-9871-3F9629D31EC7Q37628354-7C13027D-0CFC-4C52-8970-ECBE17A8AE05Q37844624-AAD72577-708A-4B20-B6FD-4DD68F566A07Q37895716-B40D8791-42DA-4D63-9530-E1953778743BQ38117647-AC6A3DFE-35BC-4F8C-9E93-A42AF368DB6DQ38532642-553A1FB0-70C8-4175-BD6D-3FAB4AC4121DQ39777283-0D807BFC-277C-429F-B7F1-49CC6E134C29Q41812558-B724A439-05F8-409E-8D02-3E591E9B7570Q44073710-6EDA0EAC-BFED-4571-9E12-59744FBB0724Q44825239-6CE2C142-4FFB-4C61-BC65-70B076096119Q45802705-336881D7-A885-4CD4-8848-5B9BD17661ACQ46533503-BACDBF12-D884-4E4A-9C0C-9F615A474F1EQ46703472-53478814-2F53-48B1-BDB9-C6C781933AD2Q47109079-40F6854A-17F8-40FB-A5C3-CF04D042778DQ47638812-25B425B0-E0B0-4218-904C-590F365A5987Q47791067-B5585045-7906-4EAE-9AC6-FD0AAA6F2705
P2860
Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?
@ast
Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?
@en
type
label
Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?
@ast
Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?
@en
prefLabel
Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?
@ast
Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?
@en
P1476
Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?
@en
P2093
P304
P356
10.1016/S0924-977X(99)00051-6
P407
P478
P577
1999-12-01T00:00:00Z